ELRIG WEBINAR: HOT TOPIC

Primary cells: An integral platform
for immuno-oncology research
26 November 2020, 14:00 BST
Register for this event

Thursday 26th November 2020: 14:00 BST

Scientists routinely use cell lines as healthy and diseased tissue models within drug development. They are easy to maintain, a stable platform and relatively inexpensive. However, they often do not reflect what is physiologically relevant in vivo. This is where primary cells may be a more advantageous choice for complex physiological disease and now an integral platform within Immuno-Oncology Research.

Speakers

Kristina Kremer (Miltenyi Biotec B.V. & Co. KG)
‘Density-gradient-free solutions for cell isolation’

Sofie Pattijn (ImmunXperts)
 ‘The use of primary cells for Immuno Oncology Drug Development’

Facilitator: David Blakey (MiNA Therapeutics)

With thanks to our event sponsor

Our App

ALL OUR EVENT INFORMATION IN
THE PALM OF YOUR HAND

If you plan to attend an ELRIG event download the free ELRIG app and access all our conference information and lecture schedules and more straight from your phone or pad..

Download Now
Menu